RBY rockeby biomed limited

quaterly, page-6

  1. 106 Posts.
    The following are my rough estimates based on the company announcements and some deductions:

    Sales Revenue for the past 3 qtrs were = $199k
    623k pepp tablets (pa) @ 40c (wholesale price) = $249k
    pepp sales have doubled in the past half year therefore the last qtr + this qtr should be $166k - as last qtr was only 85k in total sales revenue (& this contained bird flu test kits etc), then pepp sales should be at least $120k this qtr.
    500k avian flu tests @ $5 = $2.5m

    Therefore sales revenue this quarter of a minimum of $2.62m should be reported - assuming

    1. the wholesale price for pepp tablets is approx 1/3 of the retail price
    2. the sale price of the tests kits are $5 (I have assumed a discounted price due to the bulk order)
    3. the company has received the full money from the 500k avian bird flu tests (if they haven't then I would be concerned that the terms of the sale agreement had not been met - and this will seriously affect the projected short term profitability)

    So if the quarterly comes out with considerably less than $2.62m in sales revenue, I would be seriously concerned that the announcements made by the company were not accurate.

    Any comments?
    Cheers
    KM
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.